Company Filing History:
Years Active: 2010-2015
Title: Innovations by Dalton L Tomlinson
Introduction
Dalton L Tomlinson is a notable inventor based in Overland Park, Kansas. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of multiple sclerosis. With a total of three patents to his name, Tomlinson's work focuses on improving patient care through innovative formulations and administration methods.
Latest Patents
Tomlinson's latest patents include a reduced volume formulation of glatiramer acetate and methods of administration. One of his inventions outlines a method for reducing the frequency of relapses in patients afflicted with relapsing-remitting multiple sclerosis (RRMS). This method involves administering 0.5 ml of an aqueous pharmaceutical solution containing 20 mg of glatiramer acetate and 20 mg of mannitol. Another patent provides an improved injection assisting device, featuring an injection lock indicator designed to inform users about the locking state of the injection member. This device is engineered to contrast in color with its outer shells, enhancing usability and safety.
Career Highlights
Tomlinson is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on developing innovative solutions that address critical health challenges. His contributions have been instrumental in advancing treatment options for patients with multiple sclerosis.
Collaborations
Tomlinson has collaborated with notable colleagues, including Ayelet Altman and Doris Saltkill. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical innovation.
Conclusion
Dalton L Tomlinson's work exemplifies the impact of innovation in the pharmaceutical industry. His patents reflect a commitment to improving patient outcomes and advancing medical technology. Through his contributions, Tomlinson continues to play a vital role in the development of effective treatments for chronic conditions.